This is a working overview of evidence base, written for readers who want more than a one-paragraph summary but less than a textbook.
This page was last updated on 2025-09-11 and is reviewed periodically as new material appears.
Handling practice centers on limiting moisture, heat, and mechanical stress. Powder is typically allowed to reach room temperature before opening so that condensation does not form on the contents, and solutions are prepared with sterile or low-particulate water. Peptides can adsorb to certain plastics and membrane filters, so container and filter material is sometimes specified to reduce losses at low concentrations. Working aliquots are usually frozen separately rather than sampled repeatedly from one stock. Recording lot number, preparation date, and storage conditions supports later comparison between experiments.
Identity and purity are usually assessed by reversed-phase high-performance liquid chromatography, which separates the target peptide from truncated sequences and other synthesis by-products. Mass spectrometry, typically electrospray ionization coupled to liquid chromatography, confirms the expected mass and helps detect modifications. Amino acid analysis can verify composition when residue-level confirmation is needed. Because common impurities differ from the target by only one or two residues, chromatographic resolution often matters more than a single headline purity percentage. Impurity profiles are most informative when compared against a validated reference standard.
Lyophilized material is generally reported as stable for extended periods when kept cold, dry, and protected from light. In solution, the main degradation routes for a peptide of this type are hydrolysis of peptide bonds and aggregation. The sequence contains no cysteine, so disulfide-driven oxidation is not a primary concern, though methionine and tryptophan are also absent. Stability depends on pH, buffer composition, and concentration, with acidic conditions often reported as more favorable than neutral or alkaline ones. Repeated freeze-thaw cycles can promote aggregation, and how fast degradation proceeds at room temperature in specific formulations remains an open question.
Direct human evidence is scarce. One trial in ulcerative colitis delivered the compound by enema and produced limited publicly reported results without a clear benefit. The compound is not an approved medicine in most jurisdictions. In many markets it is sold as a research chemical; in others it falls under prescription or controlled categories. Regulators have not confirmed any claimed medical use, and product labels rarely undergo premarket review.
Most published reports describe experiments in rodents rather than in people. These studies examine outcomes in tendons, ligaments, bone, stomach lining, and intestinal tissue. In rat and mouse models, a frequently reported effect is faster healing or reduced damage. Sample sizes are usually small, and a substantial share of the work originates from a small number of research groups. Independent replication is limited, so how far the findings extend to humans remains an open question.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Typical lyophilized form |
| Solubility | Freely soluble in water | Also dissolves in common polar solvents |
| Storage temperature | Minus 20 degrees Celsius or lower | Applies to dry powder, desiccated and dark |
| Typical analytical methods | Reversed-phase HPLC and mass spectrometry | Used together for purity and identity |
| Primary degradation route | Hydrolysis and aggregation | No cysteine present, so disulfide formation is unlikely |
Human data are far more limited than animal data. A small number of clinical reports exist, generally with few participants and without the randomization or blinding expected in later-phase trials. No large, independently replicated human trial has appeared in the indexed peer-reviewed literature. Statements about effects in people therefore rest on extrapolation from animal work rather than on direct evidence, and the strength of that extrapolation remains an open question rather than a settled matter.
Proposed mechanisms include interaction with the nitric oxide system, modulation of growth factor signaling, and effects on blood vessel formation. None of these has been established as the primary mode of action, and some proposed pathways rest on indirect measurements. Whether the reported effects depend on a specific receptor has not been determined. Stability in gastric acid, unusual for a peptide of this size, is also reported in animal work, but the reason for it is not firmly established.
Published studies on BPC-157 are dominated by animal models. Commonly used endpoints include healing of surgically induced lesions in the stomach, tendon-to-bone attachment after transection, and recovery from experimentally induced vascular or intestinal damage. Many of these reports come from a small number of research groups, and the peptide is often described as acting across a wide range of tissue types. That breadth is itself a point of discussion, since one molecule influencing many unrelated systems is unusual.
Some properties, such as the peptide's sequence and molecular mass, are firmly established. Other claims, particularly about mechanism and clinical benefit, remain open questions. Proposed mechanisms include effects on nitric oxide signaling and on cell migration, but these are hypotheses supported by limited evidence. Reviewers often note that the field lacks large controlled human trials. Positive animal findings are best treated as signals for further study rather than as settled conclusions.
Most published studies examine BPC-157 in animal models rather than in humans. Common subjects include rats and mice, and researchers often use models of tissue injury, surgery, or induced inflammation. Reported endpoints include healing rates, blood vessel formation, and markers of tissue repair. These designs provide controlled comparisons, but findings in animals do not automatically transfer to people. Human clinical data remain limited and are frequently described as preliminary.
Ciramadol (WY-15,705) is an opioid analgesic that was developed in the late 1970s and is related to phencyclidine, tramadol, tapentadol and venlafaxine. It is a mixed agonist-antagonist for the μ-opioid receptor with relatively low abuse potential and a ceiling on respiratory depression which makes it a relatively safe drug. It has a slightly higher potency and effectiveness as an analgesic than codeine, but is weaker than morphine. Other side effects include sedation and nausea but these are generally less severe than with other similar drugs.
The final pile consisted of 771,000 pounds of graphite, 80,590 pounds of uranium oxide, and 12,400 pounds of uranium metal, with ten cadmium control rods. Neutron intensity was measured with a boron trifluoride counter, with the control rods removed, after the end of each shift. On 2 Dec. 1942, with k approaching 1.0, Fermi had all but one of the control rod removed, and gradually removed the last one. The neutron counter clicks increased, as did the pen recorder, when Fermi announced "The pile has gone critical." They had achieved a k of 1.006, which meant neutron intensity doubled every two minutes, in addition to breeding plutonium.
=== Phase 1/2 === Ambroxol – β-glucocerebrosidase (GCase) activator and/or chaperone [61] ANPD-001 (A9-line dopamine neuron therapy) – dopaminergic cell replacement [62] CT1-DAP001/DSP-1083 (allo iPS cell-derived dopamine neural progenitor) – dopaminergic cell replacement [63] EC-5026 (BPN-19186) – epoxide hydrolase inhibitor [64] HER-096 (CDNF; cerebral dopamine neurotrophic factor; rhCDNF) – neuron modulator [65] IPT-803 – dopamine modulator and opioid receptor antagonist [66] Liposomal GM1 (GM1-Gangliosid; Talineuren; TLGM-1; TLN-1; TLSG-1) – undefined mechanism of action [67] NouvNeu-001 (human dopaminergic progenitor cells) – cell replacement [68] TED-A9 (A9-DPC; allogenic embryonic stem cell-derived A9 dopamine progenitor cell therapy; TED-A9) – dopaminergic cell replacement [69] Trapidil (SB-0107) – undefined mechanism of action [70] XC-130 (XC130; XC130-A10H) – dopamine receptor agonist, other actions [71]
=== GnRH analogues === Analogs of gonadotropin-releasing hormone (GnRH) can be used to induce a chemical castration, that is, complete suppression of the production of estrogen and progesterone from the female ovaries, or complete suppression of testosterone production from the male testes. This is due to a negative feedback effect of continuous stimulation of the pituitary gland by these hormones. Leuprorelin and goserelin are GnRH analogs which are used primarily for the treatment of hormone-responsive prostate cancer. Because the initial endocrine response to GnRH analogs is actually hypersecretion of gonadal steroids, hormone receptor antagonists such as flutamide are typically used to prevent a transient boost in tumor growth.
== Function == ADP-ribosylation factor 1 (ARF1) is a member of the human ARF gene family. The family members encode small guanine nucleotide-binding proteins that stimulate the ADP-ribosyltransferase activity of cholera toxin and play a role in vesicular trafficking as activators of phospholipase D. The gene products, including 6 ARF proteins and 11 ARF-like proteins, constitute a family of the RAS superfamily. The ARF proteins are categorized as class I (ARF1, ARF2 and ARF3), class II (ARF4 and ARF5) and class III (ARF6), and members of each class share a common gene organization. The ARF1 protein is localized to the Golgi apparatus and has a central role in intra-Golgi transport. Multiple alternatively spliced transcript variants encoding the same protein have been found for this gene. The major mechanism of action of Brefeldin A is through inhibition of ARF1.
Sources: en.wikipedia.org
HA and HA fragment-tumor cell interaction could activate the downstream signaling pathways, promoting cell proliferation, adhesion, migration and invasion, and inducing angiogenesis, lymphangiogenesis, epithelial-mesenchymal transition, stem cell-like property, and chemoradioresistance in digestive cancers.
The black mamba (Dendroaspis polylepis) is a large and highly venomous snake species native to much of Sub-Saharan Africa. It is the second-longest venomous snake species in the world and is the fastest-moving land snake, capable of moving at 4.3 to 5.4 metres per second (16–20 km/h, 10–12 mph). The black mamba is the most feared snake in Africa because of its size, aggression, venom toxicity and speed of onset of symptoms following envenomation, and is classified as a snake of medical importance by the World Health Organization. This species of snake shows tenacity, fearlessness, and aggression when cornered or threatened, during breeding season, or when defending its territory. They are also known to have up to a 100% rate of envenomation; the probability of dry bites (no venom injected) in black mamba strikes is almost non-existent. The venom of the black mamba is a protein of low molecular weight and as a result is able to spread rapidly within the bitten tissue. The venom is the most rapid-acting venom of any snake species and consists mainly of highly potent neurotoxins; it also contains cardiotoxins, fasciculins, and calciseptine. Based on the median lethal dose (LD50) values in mice, the black mamba LD50 from all published sources is as follows:
=== Missing and identification === According to UNICEF, the standard system for identifying, documenting, tracing and reuniting children with relatives or siblings was barely functional in early December 2023. Additional difficulties arose from the intensity of the fighting and the rapidly changing conditions in Gaza, which hindered efforts to communicate with hospitals and medical staff. Four months into the conflict, the UN estimated that about 40% of all people in Gaza had lost identification cards and documents due to the war, making it more difficult to identify unaccompanied children and reunite them with their families. Humanitarian organizations also reported difficulties with orphaned children who were too young to know their own names. A UNICEF spokesman said: "The youngest ones very often cannot say their name and even the older ones are usually in shock so it can be extremely difficult to identify them". Hospital and emergency workers in Gaza noted that parents and relatives of some children wrote on children's bodies, mostly on their legs and abdomens, so the children would be identifiable if found in the rubble or get lost. One employee stated: "Many of the children are missing, many get here with their skulls broken… and it’s impossible to identify them, only through that writing do they get identified." In June 2024, Save the Children stated approximately 21,000 children were missing in Gaza, including 4,000 children believed to be buried under rubble. The bodies of some of these children remained unrecovered.
The toxicological cause of the disease has been attributed to the neurotoxin ODAP which acts as a structural analogue of the neurotransmitter glutamate. Lathyrism can also be caused by deliberate food adulteration.
Sources: en.wikipedia.org
This was intended to demonstrate Rhodesia's continued loyalty to the Queen, but the use of the unmistakably British song at Rhodesian state occasions soon seemed "fairly ironic", as The Times put it. Salisbury started looking for a replacement anthem around the same time as its introduction of the new flag, and in 1974, after four years without an anthem ("God Save the Queen" was formally dropped in 1970), republican Rhodesia adopted "Rise, O Voices of Rhodesia", an anthem coupling original lyrics with the tune of Beethoven's "Ode to Joy". The country's head of state under the republican constitution was the President of Rhodesia, the first of whom was Dupont. State press censorship, which had been introduced on UDI, was lifted in early April 1968. Decimalisation occurred on 17 February 1970, two weeks before Rhodesia's reconstitution as a republic, with the new Rhodesian dollar replacing the pound at a rate of two dollars to each pound. Following the republic's formal declaration the next month, the Rhodesian military removed nomenclatural and symbolic references to the Crown—the Royal Rhodesian Air Force and Royal Rhodesia Regiment dropped their "Royal" prefixes after the Queen formally revoked them because of the declaration, new branch and regimental flags were designed, and the St Edward's Crown surmounting many regimental emblems was expunged in favour of the "Lion and Tusk", a motif from the coat of arms of the British South Africa Company that had been used in Rhodesian military symbolism since the 1890s.
== Description and types == The indication is a total breast weight that exceeds approximately 3% of the total body weight. There are varying definitions of what is considered to be excessive breast tissue, that is the expected breast tissue plus extraordinary breast tissue, ranging from as little as 0.6 kilograms (1.3 lb) up to 2.5 kilograms (5.5 lb) with most physicians defining macromastia as excessive tissue of over 1.5 kilograms (3.3 lb). Some resources distinguish between macromastia (Greek, macro: large, mastos: breast), where excessive tissue is less than 2.5 kg, and gigantomastia (Greek, gigantikos: giant), where excessive tissue is more than 2.5 kg. The enlargement can cause muscular discomfort and over-stretching of the skin envelope, which can lead in some cases to ulceration. Hypertrophy of the breast can affect the breasts equally, but usually affects one breast more than the other, thereby causing asymmetry, when one breast is larger than the other. The condition can also individually affect the nipples and areola instead of or in addition to the entire breast. The effect can produce a minor size variation to an extremely large breast asymmetry. Breast hypertrophy is classified in one of five ways: as either pubertal (juvenile hypertrophy), gestational (gravid macromastia), in adult women without any obvious cause, associated with penicillamine therapy, and associated with extreme obesity. Many definitions of macromastia and gigantomastia are based on the term of "excessive breast tissue", and are therefore somewhat arbitrary.
In the extreme case of performance-enhancing substances, athletes, particularly bodybuilders may choose to use illegal substances such as anabolic steroids. These compounds which are related to the hormone testosterone, can quickly build mass and strength, but have many adverse effects such as high blood pressure and negative gender specific effects. Blood doping, another illegal ergogenic, was discovered in the 1940s when it was used by World War II pilots. Blood doping also known as blood transfusions, increases oxygen delivery to exercising tissues and has been demonstrated to improve performance in endurance sports, such as long-distance cycling. Blood doping is banned by International Olympic Committee and other International Sport Authorities and Federations.
On 29 September 1923, the British government became responsible for the administration of Mandatory Palestine. Along with its longstanding control of the Persian Gulf Residency and the Aden Protectorate, and its recently acquired control of the Emirate of Transjordan and of Mandatory Iraq, the British now controlled all of the territories in the Middle East except the French Mandate for Syria and the Lebanon. In 1942, the Biltmore Program was adopted as the platform of the Zionist Organization, with an explicit call "that Palestine be established as a Jewish Commonwealth." In 1946, the Anglo-American Committee of Inquiry, also known as the Grady-Morrison Committee, noted that the demand for a Jewish State went beyond the obligations of either the Balfour Declaration or the Mandate and had been expressly disowned by the Chairman of the Jewish Agency as recently as 1932. The period of the British Mandate was characterized by a great deal of political and social unrest among the Jews, the Palestinian Arabs, and the British (for example, the 1936–1939 Arab revolt, the 1944–1948 Jewish insurgency, and the 1947–1948 civil war in Mandatory Palestine). The United Nations Partition Plan for Palestine was passed on 29 November 1947. The plan was accepted by the Jewish Agency for Palestine but was rejected by the Arab Higher Committee and by most of the Arab population. The Arab League then adopted a series of resolutions endorsing a military solution to the conflict.
==== Quantum dot in hybrid solar cells ==== Colloidal quantum dots are also used in inorganic–organic hybrid solar cells. These solar cells are attractive because of the potential for low-cost fabrication and relatively high efficiency. Incorporation of metal oxides, such as ZnO, TiO2, and Nb2O5 nanomaterials into organic photovoltaics have been commercialized using full roll-to-roll processing. A 13.2% power conversion efficiency is claimed in Si nanowire/PEDOT:PSS hybrid solar cells.
Sources: en.wikipedia.org
Reversed-phase liquid chromatography with ultraviolet detection gives a purity estimate, while mass spectrometry confirms molecular mass and flags modifications. Amino acid analysis can add compositional confirmation. Results are most meaningful when a validated reference standard is run alongside the sample.
Cold, dry, and dark conditions are standard, typically at or below minus twenty degrees Celsius for long-term holding. Vials are usually warmed to room temperature before opening to prevent condensation. Repeated warming and cooling of the same vial is generally avoided.
This depends on pH, buffer, and concentration, with acidic conditions often reported as more favorable. Hydrolysis accelerates at room temperature, so solutions are commonly prepared fresh or stored frozen in single-use aliquots. No single shelf life applies across formulations.
Animal experiments form the bulk of the published record. Rodent models of tendon, ligament, bone, and gut injury are the most common designs. Controlled human trials are rare, which limits confidence in any clinical claim.